Thermoplastic resin, method for manufacturing same, and optical lens
US-2022145004-A1 · May 12, 2022 · US
US12540215B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12540215-B2 |
| Application number | US-202217587571-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 28, 2022 |
| Priority date | Feb 27, 2019 |
| Publication date | Feb 3, 2026 |
| Grant date | Feb 3, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for forming a crystalline form or an amorphous form of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl and thermoplastic resin therefrom. According to one embodiment, a crystal solvate form of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, which contains in its crystals from 0.3 to 1.2 mol of an organic solvent per 1 mol of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, where the organic solvent is selected from the group consisting of methanol, toluene, and methyl ethyl ketone.
Opening claim text (preview).
The invention claimed is: 1 . A method of manufacturing a crystalline form A of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, wherein the crystalline form A comprises less than 0.1 mol of organic solvents per 1 mol of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl and which in an X-ray powder diffraction diagram at 22° C. and Cu-Kα radiation displays the following three reflections, quoted as 20 values: 20.9±0.2°, 21.4±0.2° and 23.7±0.2°; and at least 3 of the following reflections, quoted as 2θ values: 6.5±0.2°, 8.6±0.2°, 11.0±0.2°, 13.2±0.2°, 14.9±0.2°, 16.2±0.2°, 17.3±0.2°, 17.8±0.2°, 18.4±0.2° and 19.0±0.2°; and wherein the method comprises determining the contents of the solvent in the crystalline solvate form by gas chromatography and obtaining the X-ray powder diffraction diagram of the crystalline solvate form at 22° C. using Cu-Kα radiation. 2 . The method of manufacturing the crystalline form of claim 1 , which in a DSC recorded according to ISO 11357-3:2018 at a heating rate of 20 K/min shows an endothermic peak having an onset in the range of 112-114° C. and a peak maximum in the range from 124-126° C. 3 . A method of manufacturing a crystalline form C of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, wherein the crystalline form C comprises less than 0.1 mol of organic solvents per 1 mol of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl and which in an X-ray powder diffraction diagram at 22° C. and Cu-Kα radiation displays the following three reflections, quoted as 2θ values: 5.1±0.2°, 7.6±0.2° and 21.0±0.2°; and at least 3 of the following reflections, quoted as 2θ values: 8.2±0.2°, 9.2±0.2°, 10.4±0.2°, 10.8±0.2°, 11.6±0.2°, 12.8±0.2°, 13.4±0.2°, 14.5±0.2°, 15.2±0.2°, 15.6±0.2°, 16.6±0.2°, 17.4±0.2°, 17.9±0.2°, 18.5±0.2°, 19.2±0.2°, 19.9±0.2°, 20.4±0.2°, 21.8±0.2°, 22.2±0.2°, 22.6±0.2°, 13.4±0.2°, 24.0±0.2°, 25.7±0.2°, 27.3±0.2° and 27.9±0.2°; and wherein the method comprises determining the contents of the solvent in the crystalline solvate form by gas chromatography, and obtaining the X-ray powder diffraction diagram of the crystalline solvate form at 22° C. using Cu-Kα radiation. 4 . The method of manufacturing the crystalline form of claim 3 , which in a DSC recorded according to ISO 11357-3:2018 at a heating rate of 20 K/min shows an endothermic peak having an onset in the range of 112-114° C. and a peak maximum in the range from 124-126° C. 5 . The method of manufacturing the crystalline form of any one of claim 1 or 3 , wherein the crystals have an aspect ratio of at most 5:1.
Crystalline forms, e.g. polymorphs · CPC title
Lenses · CPC title
Preparation processes · CPC title
Polyesters containing oxygen in the form of ether groups (C08G63/42, C08G63/58 take precedence) · CPC title
the aromatic ring being a naphthalene · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.